Updated Mar 20, 2021

Gene therapy to eliminate the HIV latent reservoir

Amir abbas Mohammadi koushki

Send Message

Harvard University and Johns Hopkins University propose to engineer a gene therapy that delivers a viral transcription factor to kill the HIV-infected cells.
How does your innovation work?
The proposed gene therapy would deliver a viral transcription factor to reactivate CD4 cells that are latently infected with HIV along with a suicide gene that is triggered by HIV protein production to ...
SEE ALL
Harvard University and Johns Hopkins University propose to engineer a gene therapy that delivers a viral transcription factor to kill the HIV-infected cells.
How does your innovation work?
The proposed gene therapy would deliver a viral transcription factor to reactivate CD4 cells that are latently infected with HIV along with a suicide gene that is triggered by HIV protein production to effectively kill the infected cells.
SEE LESS

Stage 2: Research & Development

Alison Hill and Daniel Scholes Rosenbloom of Harvard University in the U.S., working with Seyed Alireza Rabi and Greg Laird of Johns Hopkins University in the U.S., propose to engineer a gene therapy that could allow complete clearance of HIV from the body and a permanent cure for HIV infection.
Registered in United Statesin United States

Focus Areas:

Health, Prevention & Vaccination and Infectious & Vector Diseases

Health, Prevention & Vaccination and Infectious & Vector DiseasesSEE LESS

Implemented In:

United States

United StatesSEE LESS

1
Country Implemented In

Milestone

Date Unknown
Created
Date Unknown
New Country Implemented In
United States